Technology will soon make it possible to develop cheap, widely accessible psychoactive substances that are not harmful in the ...

Hype around a Microsoft AI agent's ability to diagnose difficult cases misses the mark and overlooks real innovation, experts ...

This is the web edition of D.C. Diagnosis, STAT's twice-weekly newsletter about the politics and policy of health and ...

The passage of President Trump's signature tax cut bill shows how the health care industry's influence is waning.

The pharmaceutical industry is criticizing the Trump administration’s plan for carrying out a critical round of Medicare drug ...

Pervasive stigma around cannabis use is leading some ER doctors to overdiagnose a rare marijuana-related syndrome.

When female athletes collapse on the playing field, they are less likely to be resuscitated than men: How gender differences ...

When CDC's ACIP panel doesn't recommend a vaccine, insurers may drop free coverage, leaving Americans to face higher costs.

WASHINGTON — A key Senate health leader is calling for this week’s meeting of the panel of vaccine advisers handpicked by Health and Human Services Secretary Robert F. Kennedy Jr. to be ...

Mehmet Oz, head of the Centers for Medicare and Medicaid Services, worked to reassure lawmakers wary of deep health care cuts in Trump's tax bill.

Insmed's CEO keeps a newspaper story from 2014 in his office. The headline: “Insmed joins the biotech trash heap.” Now, he hopes the company can be a $100 billion biotech.

On the surface, the National Institutes of Health’s brand new autism research initiative is alluring: $50 million to study autism’s causes and services for autistic people, and access to data ...